Healthcare
Hospitals
from 319 today
JLHL reported Q1 consolidated EBITDA growing 1% YoY to Rs 793mn. Given its expansion plans, scale-up in occupancy and improving margins, growth momentum is expected to sustain over the medium term, and we maintain our BUY rating with a TP of Rs360/share.
Ratings and target prices as published by each firm. Each summary condenses that firm's stated view in its own note and is attributed to it; no report text is reproduced.
